HIV Prevention Studies


A Phase 2B clinical trial to evaluate the safety and drug levels of a human monoclonal antibody (VRC01) administered in multiple doses intravenously and subcutaneously in different dosing schedules to healthy, HIV-uninfected adults. This strategy is called passive immunization, or antibody-mediated prevention (AMP).   Purpose of the Study Primary objective 1: To evaluate the […]

AMP Study: A Passive Immunization Clinical Trial for HIV-Negative Adults